Biotech Stock Roundup REGN Q2 Earnings Beat, BLUE, BYSIs Updates More - Yahoo New Zealand News
BYSI Stock | USD 1.89 0.04 2.16% |
Under 63% of all BeyondSpring's traders are looking to take a long position. The analysis of the overall investor sentiment regarding BeyondSpring suggests that some traders are interested. BeyondSpring's investing sentiment shows overall attitude of investors towards BeyondSpring.
BeyondSpring |
Biotech Stock Roundup REGN Q2 Earnings Beat, BLUE, BYSIs Updates More Yahoo New Zealand News
Read at news.google.com
BeyondSpring Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards BeyondSpring can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
BeyondSpring Fundamental Analysis
We analyze BeyondSpring's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeyondSpring using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeyondSpring based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
BeyondSpring is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
BeyondSpring Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BeyondSpring stock to make a market-neutral strategy. Peer analysis of BeyondSpring could also be used in its relative valuation, which is a method of valuing BeyondSpring by comparing valuation metrics with similar companies.
Peers
BeyondSpring Related Equities
FBRX | Forte Biosciences | 18.65 | ||||
SRZN | Surrozen | 8.96 | ||||
CADL | Candel Therapeutics | 7.14 | ||||
ADTX | Aditxt | 6.06 | ||||
ONCT | Oncternal Therapeutics | 5.63 | ||||
MCRB | Seres Therapeutics | 4.55 | ||||
INKT | Mink Therapeutics | 4.35 | ||||
SCPH | Scpharmaceuticals | 3.89 | ||||
RVPH | Reviva Pharmaceuticals | 1.79 | ||||
MIST | Milestone Pharmaceuticals | 1.08 | ||||
PLX | Protalix Biotherapeutics | 0.60 | ||||
EYPT | Eyepoint Pharmaceuticals | 0.56 | ||||
ALVR | Allovir | 1.82 | ||||
ONCY | Oncolytics Biotech | 2.11 | ||||
ARMP | Armata Pharmaceuticals | 2.13 | ||||
SLS | Sellas Life | 2.50 | ||||
KTTA | Pasithea Therapeutics | 3.65 |
Complementary Tools for BeyondSpring Stock analysis
When running BeyondSpring's price analysis, check to measure BeyondSpring's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeyondSpring is operating at the current time. Most of BeyondSpring's value examination focuses on studying past and present price action to predict the probability of BeyondSpring's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeyondSpring's price. Additionally, you may evaluate how the addition of BeyondSpring to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |